Search Results - Y. Pointreau

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer by Y. Pointreau, C. Freneaux, T. Bejan-Angoulvant, D. Ternant, G. Calais, H. Watier

    Published in Immuno-Oncology and Technology (2025-03-01)
    Get full text
    Article


  2. 2

    Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib by J. Chamois, A.L. Septans, B. Schipman, E. Gross, N. Blanchard, V. Passerat, C. Debelleix, C.G. Hemery, I. Latorzeff, Y. Pointreau

    Get full text
    Article


  3. 3

    Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis by C. Yuste, V. Passerat, G. Calais, B. Schipman, L. Vaugier, A. Paumier, A. Huertas, CG. Hemery, C. Debelleix, J. Chamois, N. Blanchard, AL. Septans, Y. Pointreau

    Get full text
    Article


  4. 4

    Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma by J.-P. Machiels, Y. Tao, L. Licitra, B. Burtness, M. Tahara, D. Rischin, G. V. Alves, I. P. F. Lima, B. G. M. Hughes, Y. Pointreau, S. Aksoy, S. Laban, R. Greil, M. Burian, M. Hetnal, J.-P. Delord, R. Mesia, M. Taberna, J. Waldron, C. Simon, V. Gregoire, K. Harrington, C. M. Black, J. M. Norquist, A. Wang, B. Gumuscu, B. Bidadi, L. L. Siu

    Published in Frontiers in Oncology (2025-10-01)
    Get full text
    Article


Search Tools: